Literature DB >> 8777340

Early timed follicular aspiration prevents severe ovarian hyperstimulation syndrome.

T Tomazevic1, H Meden-Vrtovec.   

Abstract

PURPOSE: Early timed follicular aspiration (ETFA) of one ovary 10-12 hr after administration of chorionic gonadotropin (hCG) is an attempt to prevent severe ovarian hyperstimulation syndrome (OHSS). After the introduction of early timed follicular aspiration ETFA of one ovary in IVF/ET cycles at high risk for severe OHSS, no cases of severe OHSS were registered in the Ljubljana IVF/ET program. In the period before preventive ETFA (1984-1992) there were 16 cases of severe OHSS of 4798 IVF/ET cycles followed by 577 clinical pregnancies. After the introduction of ETFA (1992-1993) there were no cases of severe OHSS of 2289 IVF/ET cycles followed by 364 clinical pregnancies.
METHODS: We attempted to evaluate the significance of this observation by comparing two groups of female infertility IVF/ET cycles at high risk for severe OHSS. The occurrence of severe OHSS and clinical parameters in the two groups of IVF/ET cycles at high risk for severe OHSS were compared.
RESULTS: In the group of 106 IVF/ET female infertility cycles at high risk of severe OHSS with preventive ETFA, there were no cases of severe OHSS. In the control group of 92 IVF/ET female infertility cycles at high risk for severe OHSS with normally timed follicular aspiration (NTFA) of both ovaries, severe OHSS occurred in 16 cases. The difference in the occurrence of severe OHSS between the two groups is highly significant (P < 0.005), both in hMG/hCG- and in GnRHa/hMG/hCG-induced IVF/ET cycles. No difference in live birth rate (16 vs. 16%) between the two groups was noted.
CONCLUSIONS: Considering these results we conclude that ETFA is another successful option to decrease the incidence of severe OHSS in assisted reproduction. The preventive effect of follicular aspiration seems to depend on its timing.

Entities:  

Mesh:

Year:  1996        PMID: 8777340     DOI: 10.1007/bf02070139

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  17 in total

Review 1.  Ovarian hyperstimulation syndrome: a review of pathophysiology.

Authors:  P A Bergh; D Navot
Journal:  J Assist Reprod Genet       Date:  1992-10       Impact factor: 3.412

Review 2.  Ovarian hyperstimulation syndrome: a current survey.

Authors:  J G Schenker; D Weinstein
Journal:  Fertil Steril       Date:  1978-09       Impact factor: 7.329

Review 3.  Prevention and treatment of ovarian hyperstimulation.

Authors:  J G Schenker
Journal:  Hum Reprod       Date:  1993-05       Impact factor: 6.918

4.  In vivo and in vitro maturation of human oocytes: effects on embryo development and polyspermic fertilization.

Authors:  M E Jamieson; R Fleming; S Kader; K S Ross; R W Yates; J R Coutts
Journal:  Fertil Steril       Date:  1991-07       Impact factor: 7.329

Review 5.  Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment.

Authors:  D Navot; P A Bergh; N Laufer
Journal:  Fertil Steril       Date:  1992-08       Impact factor: 7.329

6.  Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer.

Authors:  G Sher; R Salem; M Feinman; S Dodge; C Zouves; V Knutzen
Journal:  Obstet Gynecol       Date:  1993-06       Impact factor: 7.661

7.  Repeated aspiration of ovarian follicles and early corpus luteum cysts in an in-vitro fertilization programme reduces the risk of ovarian hyperstimulation syndrome in high responders.

Authors:  A Amit; Y Yaron; I Yovel; M R Peyser; M P David; A Botchan; J B Lessing
Journal:  Hum Reprod       Date:  1993-08       Impact factor: 6.918

8.  Follicular aspiration does not protect against the development of ovarian hyperstimulation syndrome.

Authors:  M A Aboulghar; R T Mansour; G I Serour; I Elattar; Y Amin
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

9.  Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups.

Authors:  R H Asch; H P Li; J P Balmaceda; L N Weckstein; S C Stone
Journal:  Hum Reprod       Date:  1991-11       Impact factor: 6.918

10.  Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.

Authors:  H M Vrtovec; T Tomazevic
Journal:  J Reprod Med       Date:  1995-01       Impact factor: 0.142

View more
  10 in total

1.  No association between the microsatellite polymorphism (TTTTA)n in the promoter of the CYP11A gene and ovarian hyperstimulation syndrome.

Authors:  Polonca Ferk; Ksenija Gersak; Natasa Teran
Journal:  J Assist Reprod Genet       Date:  2006-01-04       Impact factor: 3.412

2.  A new treatment to avoid severe ovarian hyperstimulation utilizing insights from in vitro maturation therapy.

Authors:  B I Rose
Journal:  J Assist Reprod Genet       Date:  2013-12-01       Impact factor: 3.412

Review 3.  Computerized detection and recognition of follicles in ovarian ultrasound images: a review.

Authors:  Božidar Potočnik; Boris Cigale; Damjan Zazula
Journal:  Med Biol Eng Comput       Date:  2012-09-26       Impact factor: 2.602

4.  Prevention of ovarian hyperstimulation syndrome by early aspiration of small follicles in hyper-responsive patients with polycystic ovaries during assisted reproductive treatment cycles.

Authors:  Oluseye A Oyawoye; Bina Chander; Jocelyn Hunter; Ahmed Abdel Gadir
Journal:  MedGenMed       Date:  2005-08-16

Review 5.  Prediction, assessment, and management of suboptimal GnRH agonist trigger: a systematic review.

Authors:  Hadas Ganer Herman; Eran Horowitz; Yossi Mizrachi; Jacob Farhi; Arieh Raziel; Ariel Weissman
Journal:  J Assist Reprod Genet       Date:  2022-03-19       Impact factor: 3.412

6.  Failure of GnRH agonist-triggered oocyte maturation: its cause and management.

Authors:  Yoshimasa Asada; Fumiaki Itoi; Hiroyuki Honnma; Shuji Takiguchi; Noritaka Fukunaga; Yoshiki Hashiba; Tsuyoshi Baba; Toshiaki Endo
Journal:  J Assist Reprod Genet       Date:  2013-03-15       Impact factor: 3.412

7.  Mild/minimal stimulation protocol for ovarian stimulation of patients at high risk of developing ovarian hyperstimulation syndrome.

Authors:  L Rinaldi; F Lisi; H Selman
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

8.  Efficacy and Safety of gonadotropin-releasing hormone (GnRH) Agonists Triptorelin Acetate and Cetrorelix Acetate in Assisted Reproduction.

Authors:  Jingjing Jiang; Shanshan Gao; Jin Xu
Journal:  Med Sci Monit       Date:  2018-11-08

9.  Reproductive outcome following thawed embryo transfer in management of ovarian hyperstimulation syndrome.

Authors:  Forouzan Absalan; Alireza Ghannadi; Marjaneh Kazerooni
Journal:  J Reprod Infertil       Date:  2013-07

10.  Follicular aspiration versus coasting for ovarian hyper-stimulation syndrome prevention.

Authors:  Nayla J Bushaqer; Nawal M Dayoub; Khalsa K AlHattali; Hisham A Ayyoub; Samaher S AlFaraj; Samar N Hassan
Journal:  Saudi Med J       Date:  2018-03       Impact factor: 1.484

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.